Start with the exact name on the proposed prescription
The manufacturer identifies Blender as a prescription cream containing hydroquinone USP 4%, equivalent to 40 mg per gram. Its public purchase route is through a healthcare provider or physician finder. We did not find a current direct Rx checkout price on that page. A physician listing also does not tell us which practice has stock today.
The separate Blend Fx page describes arbutin and explicitly says hydroquinone-free. Its displayed $125 price belongs to that cosmetic. Importing that number, its customer rating or its purchase terms into a Blender Rx review would produce a misleading comparison. Keep the whole product name beside any quotation you receive.
A useful written request is: please identify the prescribed product, manufacturer, strength, package quantity and dispenser. If a photograph and invoice appear to describe different names, resolve the mismatch before relying on either. Our prescription guide explains why an available listing is only one part of understanding the offer.
The label trail contains more than one date
Obagi's live Blender page links a three-page prescribing PDF marked revised July 2010. That insert lists 57 g and 28.5 g Blender bottles. The separate DailyMed record carries a March 2018 revision and describes 57 g and 28 g presentations. These are historical records, not proof that either smaller presentation is currently supplied.
The documents also differ in treatment-direction wording. We have kept their dates visible instead of combining them into a new instruction. Ask the dispensing professional for the information applicable to the actual package and prescription. A more recently accessed web page does not make an old insert newly revised.
This distinction matters when comparing costs. Dividing an unverified price by a historical bottle size would create an apparently precise calculation from two uncertain inputs. Obtain both from the same current quote before using cost per gram, and remember that package weight does not determine your prescribed duration.
Read the base as well as the active ingredient
The current page lists glycerin, cetyl alcohol, lactic acid, sodium lauryl sulfate and sodium metabisulfite among the inactive ingredients. It does not list tretinoin as an active ingredient in this Blender cream. The complete base belongs in an allergy or tolerance discussion even though the headline emphasizes hydroquinone.
The manufacturer specifically warns about sulfite reactions in susceptible people, including serious allergic or asthmatic reactions. Share relevant allergies and asthma history with the prescriber. Difficulty breathing or severe swelling calls for urgent medical help; a product review or routine customer-support queue is not an appropriate place to wait.
The word Blender is not an instruction to mix medicines yourself. If a clinician proposes another product alongside it, request the exact written plan. Ask which preparation goes where, what changes around a procedure and whom to contact if instructions conflict. The combination-cream guide helps keep those details together.
Prescription labeling does not settle FDA approval
The DailyMed entry explicitly states that this drug has not been found by FDA to be safe and effective and that its labeling is not FDA-approved. The existence of a government-hosted label or an NDC is therefore not a basis for describing Blender as an FDA-approved finished drug.
That finding also should not be stretched into a claim that every listed product is identical in regulatory status. The Clear review covers its own records, and the prescription guide distinguishes named products from compounded preparations. A familiar active ingredient does not transfer one product's approval or trial evidence to another.
We did not identify a direct clinical comparison establishing Blender as superior to the reviewed services. A manufacturer's description of what an ingredient does is different from a trial of this exact finished cream against those alternatives. We have consequently not assigned a clinical score or predicted an individual result.
Arrange the care around the bottle
AAD guidance places pigmentation treatment within an individual assessment and broader care plan. It does not identify one best treatment for everyone with melasma. A product name cannot establish whether a particular mark is melasma, another pigment condition or something requiring a different examination.
Ask for a review date and a way to reach the clinical team sooner. Discuss your existing skincare, prior reactions, pregnancy or nursing circumstances when relevant, and planned cosmetic treatments. Read the separate guides to irritation and allergy, pregnancy and breastfeeding and chemical-peel consultations.
Sun protection is part of the manufacturer's warnings and AAD's broader guidance. The practical plan should account for work, travel and time outdoors. Our sun-protection guide provides questions to discuss without turning this review into a treatment schedule.
Compare the complete proposal
CoreAge Rx Spot On publicly names hydroquinone, kojic acid and niacinamide and advertises a starting price. It is a different compounded preparation and care pathway. The CoreAge review explains the disclosed commercial relationship and the formula and billing details still requiring confirmation.
For Blender, record the consultation charge, medication quantity, delivery cost, follow-up arrangements and whether another prescribed product is included or separate. Ask how a clinical decision to stop or change treatment affects any planned purchase. A cream price alone cannot describe the full cost of care.
Use the provider board to compare one topic at a time. Blender adds a specific product record, not an additional independent clinical victory for its manufacturer. Its useful documented features are the named active strength, physician purchase route and accessible historical labeling; current local price, stock and the individual care plan remain questions for the provider.